• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Earnings Scheduled For October 28, 2022

    10/28/22 4:41:07 AM ET
    $AB
    $ABBV
    $AC
    $AON
    Investment Managers
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $AB alert in real time by email

    Companies Reporting Before The Bell

    • TAL Education (NYSE:TAL) is projected to report quarterly earnings at $0.01 per share on revenue of $242.62 million.

    • BBVA (NYSE:BBVA) is estimated to report earnings for its third quarter.

    • Equinor (NYSE:EQNR) is likely to report earnings for its third quarter.

    • Standard Motor Products (NYSE:SMP) is likely to report quarterly earnings at $0.97 per share on revenue of $378.13 million.

    • Cowen (NASDAQ:COWN) is projected to report quarterly earnings at $0.69 per share on revenue of $295.61 million.

    • Carter's (NYSE:CRI) is projected to report quarterly earnings at $1.70 per share on revenue of $853.58 million.

    • Imperial Oil (AMEX:IMO) is expected to report quarterly earnings at $2.82 per share on revenue of $18.82 billion.

    • Associated Capital Group (NYSE:AC) is projected to report quarterly earnings at $0.40 per share on revenue of $5.01 billion.

    • JinkoSolar Holding Co (NYSE:JKS) is likely to report quarterly earnings at $0.71 per share on revenue of $2.60 billion.

    • Criteo (NASDAQ:CRTO) is estimated to report quarterly earnings at $0.49 per share on revenue of $226.89 million.

    • Stellar Bancorp (NASDAQ:STEL) is expected to report quarterly earnings at $0.82 per share on revenue of $85.82 million.

    • Professional Holding (NASDAQ:PFHD) is likely to report quarterly earnings at $0.57 per share on revenue of $24.61 million.

    • Piper Sandler (NYSE:PIPR) is expected to report quarterly earnings at $2.04 per share on revenue of $321.60 million.

    • DT Midstream (NYSE:DTM) is likely to report quarterly earnings at $0.90 per share on revenue of $227.05 million.

    • Fomento Economico (NYSE:FMX) is estimated to report quarterly earnings at $1.02 per share on revenue of $8.04 billion.

    • Ranger Energy Services (NYSE:RNGR) is likely to report quarterly earnings at $0.29 per share on revenue of $166.40 million.

    • NextEra Energy Partners (NYSE:NEP) is expected to report quarterly earnings at $0.71 per share on revenue of $366.57 million.

    • US Silica Holdings (NYSE:SLCA) is expected to report quarterly earnings at $0.37 per share on revenue of $402.15 million.

    • nVent Electric (NYSE:NVT) is likely to report quarterly earnings at $0.59 per share on revenue of $706.36 million.

    • Civeo (NYSE:CVEO) is expected to report quarterly earnings at $0.23 per share on revenue of $173.56 million.

    • LyondellBasell Industries (NYSE:LYB) is likely to report quarterly earnings at $3.02 per share on revenue of $12.85 billion.

    • Gorman-Rupp (NYSE:GRC) is likely to report quarterly earnings at $0.36 per share on revenue of $136.13 million.

    • NatWest Group (NYSE:NWG) is projected to report earnings for its third quarter.

    • WisdomTree Inv (NASDAQ:WETF) is estimated to report quarterly earnings at $0.06 per share on revenue of $72.93 million.

    • DaVita (NYSE:DVA) is likely to report quarterly earnings at $1.77 per share on revenue of $2.98 billion.

    • NextEra Energy (NYSE:NEE) is estimated to report quarterly earnings at $0.79 per share on revenue of $5.74 billion.

    • Newell Brands (NASDAQ:NWL) is expected to report quarterly earnings at $0.46 per share on revenue of $2.25 billion.

    • Bloomin Brands (NASDAQ:BLMN) is likely to report quarterly earnings at $0.34 per share on revenue of $1.05 billion.

    • Eni (NYSE:E) is estimated to report earnings for its third quarter.

    • AllianceBernstein Holding (NYSE:AB) is expected to report quarterly earnings at $0.60 per share on revenue of $784.41 million.

    • Aon (NYSE:AON) is likely to report quarterly earnings at $1.99 per share on revenue of $2.81 billion.

    • First Hawaiian (NASDAQ:FHB) is projected to report quarterly earnings at $0.54 per share on revenue of $211.27 million.

    • Newmark Group (NASDAQ:NMRK) is projected to report quarterly earnings at $0.42 per share on revenue of $736.46 million.

    • Fortis (NYSE:FTS) is projected to report quarterly earnings at $0.69 per share on revenue of $2.37 billion.

    • Dime Community Bancshares (NASDAQ:DCOM) is projected to report quarterly earnings at $0.91 per share on revenue of $95.17 million.

    • Provident Finl Services (NYSE:PFS) is expected to report quarterly earnings at $0.58 per share on revenue of $105.53 million.

    • Gentex (NASDAQ:GNTX) is expected to report quarterly earnings at $0.38 per share on revenue of $496.29 million.

    • Avantor (NYSE:AVTR) is estimated to report quarterly earnings at $0.34 per share on revenue of $1.88 billion.

    • Barnes Gr (NYSE:B) is estimated to report quarterly earnings at $0.49 per share on revenue of $325.54 million.

    • Chart Industries (NYSE:GTLS) is likely to report quarterly earnings at $1.35 per share on revenue of $449.97 million.

    • Cumulus Media (NASDAQ:CMLS) is estimated to report quarterly earnings at $0.48 per share on revenue of $232.23 million.

    • Sanofi (NASDAQ:SNY) is expected to report quarterly earnings at $1.33 per share on revenue of $11.38 billion.

    • W.W. Grainger (NYSE:GWW) is estimated to report quarterly earnings at $7.20 per share on revenue of $3.89 billion.

    • Charter Communications (NASDAQ:CHTR) is estimated to report quarterly earnings at $8.28 per share on revenue of $13.68 billion.

    • Church & Dwight Co (NYSE:CHD) is likely to report quarterly earnings at $0.65 per share on revenue of $1.30 billion.

    • Colgate-Palmolive (NYSE:CL) is expected to report quarterly earnings at $0.74 per share on revenue of $4.49 billion.

    • Booz Allen Hamilton (NYSE:BAH) is projected to report quarterly earnings at $1.14 per share on revenue of $2.26 billion.

    • AbbVie (NYSE:ABBV) is projected to report quarterly earnings at $3.59 per share on revenue of $14.96 billion.

    • Banco Santander Chile (NYSE:BSAC) is projected to report quarterly earnings at $0.48 per share on revenue of $628.20 million.

    • Chevron (NYSE:CVX) is projected to report quarterly earnings at $4.91 per share on revenue of $59.17 billion.

    • Exxon Mobil (NYSE:XOM) is expected to report quarterly earnings at $3.65 per share on revenue of $134.28 billion.

    • Itau Corpbanca (NYSE:ITCB) is likely to report earnings for its third quarter.

    Companies Reporting After The Bell

    • Sisecam Resources (NYSE:SIRE) is expected to report earnings for its third quarter.

    • Central North Airport Gr (NASDAQ:OMAB) is projected to report quarterly earnings at $0.72 per share on revenue of $98.50 million.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $AB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AB
    $ABBV
    $AC
    $AON

    CompanyDatePrice TargetRatingAnalyst
    Equinor ASA
    $EQNR
    2/5/2026$22.00 → $25.00Hold
    TD Cowen
    Equinor ASA
    $EQNR
    2/5/2026Buy → Neutral
    BofA Securities
    Exxon Mobil Corporation
    $XOM
    2/3/2026$125.00Neutral → Underperform
    BNP Paribas Exane
    Exxon Mobil Corporation
    $XOM
    2/3/2026$135.00 → $145.00Buy
    TD Cowen
    Chevron Corporation
    $CVX
    2/2/2026$160.00 → $168.00Hold
    TD Cowen
    Chevron Corporation
    $CVX
    2/2/2026$180.00Buy → Hold
    HSBC Securities
    Church & Dwight Company Inc.
    $CHD
    2/2/2026$100.00Underweight → Neutral
    Analyst
    TAL Education Group
    $TAL
    1/30/2026$18.00Neutral → Outperform
    Macquarie
    More analyst ratings

    $AB
    $ABBV
    $AC
    $AON
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Leopold Diane bought $179,703 worth of Ordinary Shares (2,000 units at $89.85) (SEC Form 4)

    4 - nVent Electric plc (0001720635) (Issuer)

    1/16/26 5:49:56 PM ET
    $NVT
    Industrial Machinery/Components
    Industrials

    Director Mehra Sanjeev K was granted 8,106 shares and bought $3,881,500 worth of shares (350,000 units at $11.09) (SEC Form 4)

    4 - Avantor, Inc. (0001722482) (Issuer)

    12/9/25 5:11:24 PM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    President and CEO Ligner Emmanuel bought $993,125 worth of shares (87,500 units at $11.35), increasing direct ownership by 45% to 283,424 units (SEC Form 4)

    4 - Avantor, Inc. (0001722482) (Issuer)

    11/17/25 5:45:30 PM ET
    $AVTR
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $AB
    $ABBV
    $AC
    $AON
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    March 28, 2025 - FDA Approves Novel Treatment for Hemophilia A or B, with or without Factor Inhibitors

    For Immediate Release: March 28, 2025 Today, the U.S. Food and Drug Administration approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A or hemophilia B, with or without factor VIII or IX inhibitors (neutralizing antibodies).“Today’s approval of Qfitlia is significant for patients wi

    3/28/25 10:17:55 PM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    February 14, 2025 - FDA Approves First Rapid-Acting Insulin Biosimilar Product for Treatment of Diabetes

    For Immediate Release: February 14, 2025 Today, the U.S. Food and Drug Administration approved Merilog (insulin-aspart-szjj) as biosimilar to Novolog (insulin aspart) for the improvement of glycemic control in adults and pediatric patients with diabetes mellitus. Merilog, a rapid-acting human insulin analog, is the first rapid-acting insulin biosimilar product approved by the FDA. As a rapid-acting insulin, Meri

    2/14/25 3:00:13 PM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for SOLIQUA 100/33 issued to SANOFI-AVENTIS US

    Submission status for SANOFI-AVENTIS US's drug SOLIQUA 100/33 (SUPPL-14) with active ingredient INSULIN GLARGINE; LIXISENATIDE has changed to 'Approval' on 11/01/2024. Application Category: BLA, Application Number: 208673, Application Classification:

    11/4/24 4:49:34 AM ET
    $SNY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AB
    $ABBV
    $AC
    $AON
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 5 filed by Longo Joseph James

    5 - CHURCH & DWIGHT CO INC /DE/ (0000313927) (Issuer)

    2/11/26 2:50:30 PM ET
    $CHD
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 5 filed by Dierker Richard A

    5 - CHURCH & DWIGHT CO INC /DE/ (0000313927) (Issuer)

    2/11/26 2:00:54 PM ET
    $CHD
    Package Goods/Cosmetics
    Consumer Discretionary

    SEC Form 5 filed by De Maynadier Patrick D

    5 - CHURCH & DWIGHT CO INC /DE/ (0000313927) (Issuer)

    2/11/26 1:37:18 PM ET
    $CHD
    Package Goods/Cosmetics
    Consumer Discretionary

    $AB
    $ABBV
    $AC
    $AON
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen reiterated coverage on Equinor with a new price target

    TD Cowen reiterated coverage of Equinor with a rating of Hold and set a new price target of $25.00 from $22.00 previously

    2/5/26 7:02:53 AM ET
    $EQNR
    Integrated oil Companies
    Energy

    Equinor downgraded by BofA Securities

    BofA Securities downgraded Equinor from Buy to Neutral

    2/5/26 6:53:33 AM ET
    $EQNR
    Integrated oil Companies
    Energy

    Exxon Mobil downgraded by BNP Paribas Exane with a new price target

    BNP Paribas Exane downgraded Exxon Mobil from Neutral to Underperform and set a new price target of $125.00

    2/3/26 6:52:02 AM ET
    $XOM
    Integrated oil Companies
    Energy

    $AB
    $ABBV
    $AC
    $AON
    SEC Filings

    View All

    SEC Form 6-K filed by Fortis Inc.

    6-K - Fortis Inc. (0001666175) (Filer)

    2/12/26 6:07:19 AM ET
    $FTS
    Electric Utilities: Central
    Utilities

    SEC Form 40-F filed by Fortis Inc.

    40-F - Fortis Inc. (0001666175) (Filer)

    2/12/26 6:05:30 AM ET
    $FTS
    Electric Utilities: Central
    Utilities

    SEC Form 6-K filed by Fortis Inc.

    6-K - Fortis Inc. (0001666175) (Filer)

    2/12/26 6:00:37 AM ET
    $FTS
    Electric Utilities: Central
    Utilities

    $AB
    $ABBV
    $AC
    $AON
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Fortis Inc. Reports Fourth Quarter & Annual 2025 Results

    This news release constitutes a "Designated News Release" incorporated by reference in the prospectus supplement dated December 9, 2024 to Fortis' short form base shelf prospectus dated December 9, 2024. ST. JOHN'S, Newfoundland and Labrador, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Fortis Inc. ("Fortis" or the "Corporation") (TSX/NYSE:FTS), a diversified leader in the North American regulated electric and gas utility industry, released its 2025 fourth quarter and annual financial results.1 Highlights Annual net earnings of $1.7 billion, or $3.40 per common share for 2025Annual adjusted net earnings per common share2 of $3.53, up from $3.28 for 2024Capital expenditures2 of $5.6 billion,

    2/12/26 6:00:00 AM ET
    $FTS
    Electric Utilities: Central
    Utilities

    Fortis Inc. Announces Second Quarter Dividends – 2026

    This news release constitutes a "Designated News Release" incorporated by reference in the prospectus supplement dated December 9, 2024 to Fortis' short form base shelf prospectus dated December 9, 2024. ST. JOHN'S, Newfoundland and Labrador, Feb. 11, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Fortis Inc. ("Fortis" or the "Corporation") (TSX/NYSE:FTS) has declared the following dividends payable on June 1, 2026 to the Shareholders of Record of the following Shares of the Corporation at the close of business on May 15, 2026: $0.3063 per share on the First Preference Shares, Series "F";$0.3826875 per share on the First Preference Shares, Series "G"; $0.26144 per share on the First

    2/11/26 5:42:27 PM ET
    $FTS
    Electric Utilities: Central
    Utilities

    EGFR-NSCLC Market to Observe Stunning Growth at a CAGR of 9.6% During the Forecast Period (2025-2034) | DelveInsight

    The EGFR-NSCLC market is expected to grow owing to the approval of new agents such as Zipalertinib (Cullinan Oncology/Taiho Pharma), Ivonescimab (Akeso Biopharma/Summit Therapeutics), Sacituzumab Tirumotecan (Merck/Kelun-Biotech), Izalontamab Brengitecan (Bristol-Myers Squibb), Firmonertinib (ArriVent BioPharma), and others in frontline and combination settings, rising therapy costs, and increasing testing rates that enable the identification of more patients with EGFR alterations. LAS VEGAS, Feb. 11, 2026 /PRNewswire/ -- DelveInsight's EGFR-NSCLC Market Insights report includes a comprehensive understanding of current treatment practices, EGFR-NSCLC emerging drugs, market share of individua

    2/11/26 5:31:00 PM ET
    $ABBV
    $AVBP
    $BDTX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    $AB
    $ABBV
    $AC
    $AON
    Financials

    Live finance-specific insights

    View All

    Fortis Inc. Reports Fourth Quarter & Annual 2025 Results

    This news release constitutes a "Designated News Release" incorporated by reference in the prospectus supplement dated December 9, 2024 to Fortis' short form base shelf prospectus dated December 9, 2024. ST. JOHN'S, Newfoundland and Labrador, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Fortis Inc. ("Fortis" or the "Corporation") (TSX/NYSE:FTS), a diversified leader in the North American regulated electric and gas utility industry, released its 2025 fourth quarter and annual financial results.1 Highlights Annual net earnings of $1.7 billion, or $3.40 per common share for 2025Annual adjusted net earnings per common share2 of $3.53, up from $3.28 for 2024Capital expenditures2 of $5.6 billion,

    2/12/26 6:00:00 AM ET
    $FTS
    Electric Utilities: Central
    Utilities

    Fortis Inc. Announces Second Quarter Dividends – 2026

    This news release constitutes a "Designated News Release" incorporated by reference in the prospectus supplement dated December 9, 2024 to Fortis' short form base shelf prospectus dated December 9, 2024. ST. JOHN'S, Newfoundland and Labrador, Feb. 11, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Fortis Inc. ("Fortis" or the "Corporation") (TSX/NYSE:FTS) has declared the following dividends payable on June 1, 2026 to the Shareholders of Record of the following Shares of the Corporation at the close of business on May 15, 2026: $0.3063 per share on the First Preference Shares, Series "F";$0.3826875 per share on the First Preference Shares, Series "G"; $0.26144 per share on the First

    2/11/26 5:42:27 PM ET
    $FTS
    Electric Utilities: Central
    Utilities

    CRITEO REPORTS FOURTH QUARTER 2025 RESULTS

    Deployed $152 Million to Repurchase Shares in 2025 Remaining Share Buyback Authorization Increased up to $200 Million NEW YORK, Feb. 11, 2026 /PRNewswire/ -- Criteo S.A. (NASDAQ:CRTO) ("Criteo" or the "Company"), the global platform connecting the commerce ecosystem, today announced financial results for the fourth quarter and fiscal year ended December 31, 2025. Fourth Quarter and Fiscal Year 2025 Financial Highlights: The following table summarizes our consolidated financial results for the three months and twelve months ended December 31, 2025: Three Months Ended Twelve Months Ended December 31 December 31 2025 2024 YoY Change 2025 2024 YoY Change (in millions, except EPS data) GAAP Resu

    2/11/26 7:00:00 AM ET
    $CRTO
    Advertising
    Consumer Discretionary

    $AB
    $ABBV
    $AC
    $AON
    Leadership Updates

    Live Leadership Updates

    View All

    Piper Sandler Strengthens Energy & Power Investment Banking with the Addition of Tim Carlson

    Piper Sandler Companies (NYSE:PIPR), a leading investment bank, is pleased to announce the addition of Tim Carlson as a managing director on the energy & power investment banking team. Carlson will focus on upstream. "Tim is another strong example of how we are devoted to the energy sector and will continue to bring in top talent to further help our clients achieve their goals. He has been a trusted advisor to senior executives and boards of directors, known for cultivating and sustaining relationships across decades and market cycles," said Spencer Rippstein, global co-head of energy, power & infrastructure investment banking at Piper Sandler. With over 28 years of investment banking e

    1/29/26 9:01:00 AM ET
    $PIPR
    Investment Bankers/Brokers/Service
    Finance

    Barrick Announces Finance Leadership Transition

    TORONTO, Jan. 19, 2026 (GLOBE NEWSWIRE) -- Barrick Mining Corporation (NYSE:B)(TSX:ABX) ("Barrick" or the "Company") today announced the appointment of Helen Cai as Senior Executive Vice President and Chief Financial Officer. Ms. Cai will become Chief Financial Officer on March 1, 2026, following the departure of Graham Shuttleworth, who will be leaving Barrick, after the announcement and filing of the Company's year-end results. Ms. Cai will work with Mr. Shuttleworth until his departure to ensure a smooth transition. Mark Hill, Group COO and Interim President and Chief Executive, said: "I would like to welcome Helen to the executive team as CFO. Helen's deep financial expertise and deca

    1/19/26 7:00:00 AM ET
    $B
    Precious Metals
    Basic Materials

    Cumulus Media Appoints Carol Flaton to Board of Directors

    ATLANTA, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Cumulus Media Inc. (OTCQB:CMLS) today announced the appointment of Carol Flaton to its Board of Directors. Flaton's appointment follows the resignation of Joan Hogan Gillman from the Board. Both changes are effective January 15, 2026. "We are pleased to welcome Carol to our board," said Chairman Andrew W. Hobson. "She brings more than three decades of experience in financial services and governance, along with a strong track record of advising companies and serving on boards across a wide range of industries. Her insight and financial acumen will further strengthen the Board as the Company continues to execute its strategy." Hobson added, "We th

    1/15/26 8:01:00 AM ET
    $CMLS
    Broadcasting
    Consumer Discretionary

    $AB
    $ABBV
    $AC
    $AON
    Insider purchases explained

    Analytical look into recent insider purchases

    View All

    Insider Analysis: Purchase at Exxon Mobil Corporation on Jun 20

    Director Dreyfus Maria S. bought $2,000,386 worth of shares (18,310 units at $109.25), increasing direct ownership by 105% to 35,757 units (SEC Form 4) on June 20, 2024. This substantial insider purchase is a significant development for Exxon Mobil Corporation. As we delve into the recent insider activity at Exxon Mobil, we notice a few interesting patterns. Prior to Dreyfus Maria S.'s purchase, we observed that on January 4, 2024, Ubben Jeffrey W. granted 2,500 shares, which could signal confidence in the company. On the same day, Powell Dina H. claimed no ownership of stock but was granted 8,000 shares, indicating a new ownership stake. These events suggest a mix of adjustments in holding

    6/20/24 1:39:11 PM ET
    $XOM
    Integrated oil Companies
    Energy

    $AB
    $ABBV
    $AC
    $AON
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by AllianceBernstein Holding L.P.

    SC 13D/A - ALLIANCEBERNSTEIN HOLDING L.P. (0000825313) (Subject)

    4/2/25 8:51:37 AM ET
    $AB
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by Ranger Energy Services Inc.

    SC 13D/A - Ranger Energy Services, Inc. (0001699039) (Subject)

    12/12/24 6:49:54 PM ET
    $RNGR
    Oilfield Services/Equipment
    Energy

    Amendment: SEC Form SC 13D/A filed by Ranger Energy Services Inc.

    SC 13D/A - Ranger Energy Services, Inc. (0001699039) (Subject)

    12/4/24 8:57:26 PM ET
    $RNGR
    Oilfield Services/Equipment
    Energy